InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
-12.4%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Gallagher Duncan, Director. Officer active across 1 company, notably Health Catalyst, Inc.. Aggregated, 11 filings have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €157k. Activity tracked since 10 June 2021. The latest transaction was disclosed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
3,033 shares0Common StockSEC:0001562180-25-002001:0
4,500 shares@ US$6.929819.0% of flowCommon StockSEC:0001562180-25-000010:0
4,500 shares@ US$6.981219.1% of flowCommon StockSEC:0001562180-24-008598:0
2,001 shares0Common StockSEC:0001562180-24-008090:0
2,414 shares0Common StockSEC:0001562180-24-006759:0
20,807 shares0Common StockSEC:0001562180-24-005136:0
5,806 shares0Common StockSEC:0001562180-23-005294:0
8,400 shares@ US$11.6961.9% of flowCommon StockSEC:0001562180-22-006235:0
Ideal exit: 15 May 2023 (T+270)
11,677 shares0Common StockSEC:0001562180-22-005145:0
3,285 shares0Common StockSEC:0001562180-21-004245:0
3,285 shares0Common StockSEC:0001562180-21-004245
11 of 11 declarations
About Gallagher Duncan
Duncan Gallagher is a Board Member at Health Catalyst, Inc. He plays a key role in the governance of the company, providing strategic guidance to enhance performance and innovation in the healthcare sector.
